Literature DB >> 29568059

Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Arianna Bellazzo1, Giulio Di Minin2, Elena Valentino1,3, Daria Sicari1,3, Denis Torre4, Luigi Marchionni5, Federica Serpi1, Michael B Stadler6, Daniela Taverna7, Gaia Zuccolotto8, Isabella Monia Montagner9, Antonio Rosato8,9, Federica Tonon10, Cristina Zennaro10, Chiara Agostinis11, Roberta Bulla3, Miguel Mano12,13, Giannino Del Sal14,15, Licio Collavin16,17.   

Abstract

The tumor suppressor DAB2IP contributes to modulate the network of information established between cancer cells and tumor microenvironment. Epigenetic and post-transcriptional inactivation of this protein is commonly observed in multiple human malignancies, and can potentially favor progression of tumors driven by a variety of genetic mutations. Performing a high-throughput screening of a large collection of human microRNA mimics, we identified miR-149-3p as a negative post-transcriptional modulator of DAB2IP. By efficiently downregulating DAB2IP, this miRNA enhances cancer cell motility and invasiveness, facilitating activation of NF-kB signaling and promoting expression of pro-inflammatory and pro-angiogenic factors. In addition, we found that miR-149-3p secreted by prostate cancer cells induces DAB2IP downregulation in recipient vascular endothelial cells, stimulating their proliferation and motility, thus potentially remodeling the tumor microenvironment. Finally, we found that inhibition of endogenous miR-149-3p restores DAB2IP activity and efficiently reduces tumor growth and dissemination of malignant cells. These observations suggest that miR-149-3p can promote cancer progression via coordinated inhibition of DAB2IP in tumor cells and in stromal cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29568059      PMCID: PMC6030048          DOI: 10.1038/s41418-018-0088-5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  47 in total

Review 1.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

2.  Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing.

Authors:  Federica Tonon; Cristina Zennaro; Barbara Dapas; Michele Carraro; Massimo Mariotti; Gabriele Grassi
Journal:  Int J Pharm       Date:  2016-10-29       Impact factor: 5.875

Review 3.  miR-92a family and their target genes in tumorigenesis and metastasis.

Authors:  Molin Li; Xingfang Guan; Yuqiang Sun; Jun Mi; Xiaohong Shu; Fang Liu; Chuangang Li
Journal:  Exp Cell Res       Date:  2014-01-04       Impact factor: 3.905

4.  AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis.

Authors:  Weidong Ji; Yonghao Li; Yun He; Mingzhu Yin; Huanjiao Jenny Zhou; Titus J Boggon; Haifeng Zhang; Wang Min
Journal:  Cancer Res       Date:  2015-07-02       Impact factor: 12.701

5.  Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.

Authors:  M K Siu; Y-C Tsai; Y-S Chang; J J Yin; F Suau; W-Y Chen; Y-N Liu
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

6.  Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.

Authors:  Stefano Fogli; Beatrice Polini; Sara Carpi; Barbara Pardini; Alessio Naccarati; Nevio Dubbini; Maria Lanza; Maria Cristina Breschi; Antonella Romanini; Paola Nieri
Journal:  Tumour Biol       Date:  2017-05

7.  An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.

Authors:  Junxia Min; Alexander Zaslavsky; Giuseppe Fedele; Sara K McLaughlin; Elizabeth E Reczek; Thomas De Raedt; Isil Guney; David E Strochlic; Laura E Macconaill; Rameen Beroukhim; Roderick T Bronson; Sandra Ryeom; William C Hahn; Massimo Loda; Karen Cichowski
Journal:  Nat Med       Date:  2010-02-14       Impact factor: 53.440

Review 8.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

9.  AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.

Authors:  Haifeng Zhang; Rong Zhang; Yan Luo; Alessio D'Alessio; Jordan S Pober; Wang Min
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

10.  CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.

Authors:  Yoichi Matsuo; Nobuo Ochi; Hirozumi Sawai; Akira Yasuda; Hiroki Takahashi; Hitoshi Funahashi; Hiromitsu Takeyama; Zhimin Tong; Sushovan Guha
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

View more
  15 in total

1.  [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].

Authors:  Kun Cao; Liangquan Sun; Yewei Zhang; Tengfei Wang; Haiyang Li; Shi Zuo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

2.  Oncogenic and tumor-suppressive microRNAs in prostate cancer.

Authors:  Morgan L Zenner; Bethany Baumann; Larisa Nonn
Journal:  Curr Opin Endocr Metab Res       Date:  2020-02-27

3.  Circular RNA Expression Profiles and the Pro-tumorigenic Function of CircRNA_10156 in Hepatitis B Virus-Related Liver Cancer.

Authors:  Man Wang; Bianli Gu; Guoliang Yao; Peifeng Li; Kun Wang
Journal:  Int J Med Sci       Date:  2020-05-30       Impact factor: 3.738

4.  ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression.

Authors:  Ming-Hui Ma; Jia-Xiang An; Cheng Zhang; Jie Liu; Yu Liang; Chun-Dong Zhang; Zhen Zhang; Dong-Qiu Dai
Journal:  Cancer Cell Int       Date:  2019-02-06       Impact factor: 5.722

5.  Profiling and functional analysis of differentially expressed circular RNAs in high glucose-induced human umbilical vein endothelial cells.

Authors:  Guoxi Jin; Qiong Wang; Xiaolei Hu; Xiaoli Li; Xiaoyan Pei; Erqin Xu; Minglong Li
Journal:  FEBS Open Bio       Date:  2019-08-22       Impact factor: 2.693

6.  Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression.

Authors:  Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Keisuke Ae; Seiichi Matsumoto; Subbaya Subramanian; Takuro Nakamura
Journal:  Cancers (Basel)       Date:  2020-01-30       Impact factor: 6.639

7.  Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway.

Authors:  Yu Liang; Lidan Hou; Linjing Li; Lei Li; Liming Zhu; Yu Wang; Xin Huang; Yichao Hou; Danxi Zhu; Huimin Zou; Yan Gu; Xiaoling Weng; Yingying Wang; Yue Li; Tianqi Wu; Mengfei Yao; Isabelle Gross; Christian Gaiddon; Meng Luo; Jianhua Wang; Xiangjun Meng
Journal:  Oncogene       Date:  2019-10-09       Impact factor: 9.867

8.  MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1.

Authors:  Qiang Lu; Yanchun Chen; Dan Sun; Shukun Wang; Kang Ding; Meiyi Liu; Yan Zhang; Yujuan Miao; Huancai Liu; Fenghua Zhou
Journal:  Front Pharmacol       Date:  2019-01-10       Impact factor: 5.810

9.  LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.

Authors:  Aimei Zou; Xingli Liu; Zongjiong Mai; Junke Zhang; Zhuohuan Liu; Qilu Huang; Aibing Wu; Chenyu Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-15       Impact factor: 8.886

10.  Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis.

Authors:  Yang Liu; Chunyan Yang; Yong Zhao; Qiang Chi; Zhen Wang; Boshi Sun
Journal:  Aging (Albany NY)       Date:  2019-12-20       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.